Sachiko Suzuki Selected Research

ferrichrysin

1/2007

Iron chelated cyclic peptide, ferrichrysin, for oral treatment of iron deficiency: solution properties and efficacy in anemic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sachiko Suzuki Research Topics

Disease

5	Neoplasms (Cancer) 11/2010 - 08/2002
4	Infections 01/2019 - 01/2011
3	Hemorrhage 01/2020 - 07/2019
3	Neoplasm Metastasis (Metastasis) 12/2009 - 08/2002
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2021 - 10/2020
2	Hepatitis 05/2021 - 09/2015
2	Lymphoma (Lymphomas) 01/2020 - 02/2012
2	Hemophilia A (Haemophilia) 01/2020 - 10/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2015 - 07/2003
2	Disease Progression 01/2015 - 11/2010
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2015 - 08/2013
2	Liver Diseases (Liver Disease) 10/2007 - 05/2007
2	Lung Neoplasms (Lung Cancer) 11/2006 - 02/2006
2	Ovarian Epithelial Carcinoma 09/2003 - 10/2002
1	Joint Diseases (Joint Disease) 01/2020
1	Hemophilia B (Haemophilia B) 07/2019
1	Venous Thromboembolism 06/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2017
1	Thrombosis (Thrombus) 11/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2015
1	Rheumatoid Arthritis 01/2014
1	Lymphomatoid Granulomatosis (Granulomatosis, Lymphomatoid) 01/2014
1	Persistent Infection 01/2011
1	Chromosome Aberrations (Chromosome Abnormalities) 11/2010
1	Histiocytic Sarcoma 11/2010
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2009
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2009
1	Hypoxia (Hypoxemia) 09/2008
1	Cholestasis 05/2007
1	Jaundice (Icterus) 05/2007
1	Iron Deficiencies 01/2007
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2007
1	Atherosclerotic Plaque (Atheroma) 03/2006

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 05/2021 - 09/2015
3	Rituximab (Mabthera)FDA Link 05/2021 - 09/2015
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 05/2021 - 09/2015
3	Antiviral Agents (Antivirals)IBA 05/2021 - 09/2015
2	AntibodiesIBA 01/2020 - 09/2015
2	AntithrombinsIBA 06/2019 - 11/2017
2	Methotrexate (Mexate)FDA LinkGeneric 01/2014 - 09/2004
2	Biological ProductsIBA 12/2009 - 09/2008
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2006 - 02/2006
2	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 11/2006 - 02/2006
2	CholesterolIBA 11/2006 - 02/2006
2	Liposomes (Liposome)IBA 11/2006 - 02/2006
2	Carboplatin (JM8)FDA LinkGeneric 09/2003 - 10/2002
1	lipoarabinomannan (LAM)IBA 05/2021
1	Surface Antigens (Surface Antigen)IBA 05/2021
1	Alanine Transaminase (SGPT)IBA 05/2021
1	Chromogenic CompoundsIBA 01/2020
1	Factor VIII (Coagulation Factor VIII)IBA 01/2020
1	emicizumabIBA 10/2019
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 07/2019
1	InterferonsIBA 01/2019
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2019
1	Prothrombin (Factor II)IBA 11/2017
1	Hepatitis B Core AntigensIBA 09/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2015
1	SteroidsIBA 09/2015
1	RNA (Ribonucleic Acid)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	MicroRNAs (MicroRNA)IBA 01/2011
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2011
1	Serum Response FactorIBA 01/2011
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 11/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2008
1	14,15-dihydroxyeicosatrienoic acidIBA 09/2008
1	Erythropoietin FDA Link 09/2008
1	Cytochrome P-450 CYP2C8IBA 09/2008
1	Phospholipases (Phospholipase)IBA 09/2008
1	11,12-epoxy-5,8,14-eicosatrienoic acidIBA 09/2008
1	methyl arachidonylfluorophosphonateIBA 09/2008
1	14,15-epoxy-5,8,11-eicosatrienoic acidIBA 09/2008
1	LuciferasesIBA 09/2008
1	Sulfaphenazole FDA Link 09/2008
1	3- (2- (2- tert- butylphenylaminooxalyl)aminopropionylamino)- 4- oxo- 5- (2,3,5,6- tetrafluorophenoxy)pentanoic acidIBA 10/2007
1	Multidrug Resistance-Associated Protein 2IBA 05/2007
1	BilirubinIBA 05/2007
1	Heme (Haem)IBA 01/2007
1	ferrichrysinIBA 01/2007
1	ferric citrateIBA 01/2007
1	IronIBA 01/2007
1	SolutionsIBA 01/2007
1	Cyclic PeptidesIBA 01/2007
1	PropaneIBA 11/2006
1	Retinaldehyde (Retinal)IBA 11/2006
1	Cholesterol Esters (Cholesteryl Esters)IBA 03/2006

Therapy/Procedure

9	Therapeutics 05/2021 - 09/2003
8	Drug Therapy (Chemotherapy) 05/2021 - 10/2002
3	Radiotherapy 01/2014 - 08/2002
2	Induction Chemotherapy 05/2021 - 10/2020
2	Art Therapy 01/2019 - 08/2013
1	Stem Cell Transplantation 10/2020
1	Autologous Transplantation 10/2020
1	Perioperative Period 10/2019
1	Contraception (Birth Control) 01/2009
1	Oral Administration 10/2007
1	Intravenous Injections 11/2006
1	Lasers (Laser) 03/2006